LENZ Therapeutics Inc (LENZ)
16.46
+0.05
(+0.30%)
USD |
NASDAQ |
May 03, 16:00
16.50
+0.04
(+0.24%)
After-Hours: 20:00
LENZ Therapeutics Enterprise Value: 354.49M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 354.49M |
| May 02, 2024 | 353.21M |
| May 01, 2024 | 337.89M |
| April 30, 2024 | 339.42M |
| April 29, 2024 | 355.51M |
| April 26, 2024 | 335.59M |
| April 25, 2024 | 328.70M |
| April 24, 2024 | 339.17M |
| April 23, 2024 | 340.70M |
| April 22, 2024 | 339.93M |
| April 19, 2024 | 343.25M |
| April 18, 2024 | 380.79M |
| April 17, 2024 | 386.15M |
| April 16, 2024 | 442.83M |
| April 15, 2024 | 456.11M |
| Date | Value |
|---|---|
| April 12, 2024 | 493.13M |
| April 11, 2024 | 489.05M |
| April 10, 2024 | 471.18M |
| April 09, 2024 | 457.90M |
| April 08, 2024 | 455.60M |
| April 05, 2024 | 453.30M |
| April 04, 2024 | 458.41M |
| April 03, 2024 | 476.03M |
| April 02, 2024 | 470.66M |
| April 01, 2024 | 470.66M |
| March 28, 2024 | 504.37M |
| March 27, 2024 | 491.09M |
| March 26, 2024 | 361.64M |
| March 25, 2024 | 350.91M |
| March 22, 2024 | 347.85M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
328.70M
Minimum
Apr 25 2024
504.37M
Maximum
Mar 28 2024
406.18M
Average
383.47M
Median
Enterprise Value Benchmarks
| TruBridge Inc | 318.31M |
| PetMed Express Inc | 36.22M |
| Streamline Health Solutions Inc | 24.43M |
| R1 RCM Inc | 6.711B |
| MoonLake Immunotherapeutics | 2.353B |